Online citations, reference lists, and bibliographies.

Thyroid Cancer In Pediatrics.

Josef Machac
Published 2016 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Well differentiated thyroid cancer (DTC) in children is characterized by a high rate of response to treatment and low disease-specific mortality. Treatment of children with DTC has evolved toward a greater reliance on evaluation and monitoring with serial serum thyroglobulin measurements and ultrasound examinations. Radioiodine therapy is recommended for thyroid remnant ablation in high-risk patients, treatment of demonstrated radioiodine-avid local-regional disease not amenable to surgical resection, or distant radioiodine-avid metastatic disease. Sufficient time should be given for benefits of radioiodine therapy to be realized, with follow-up monitoring. Re-treatment with radioiodine can be deferred until progression of significant disease manifests.
This paper references
10.7326/0003-4819-126-3-199702010-00009
Thyroid Incidentalomas: Management Approaches to Nonpalpable Nodules Discovered Incidentally on Thyroid Imaging
G. H. Tan (1997)
10.1002/cncr.26070
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
Narayanan Gopalakrishna Iyer (2011)
10.1089/thy.2008.0238
The usual ultrasonographic features of thyroid cancer are less frequent in small tumors that develop after a long latent period after the Chernobyl radiation release accident.
Valentina M. Drozd (2009)
10.1089/10507250152484628
Long-term follow-up of patients with initially benign thyroid fine-needle aspirations.
Yair Liel (2001)
Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Massimo Eugenio Dottorini (1997)
10.1016/S0084-3741(09)79430-2
Pediatric thyroid fine-needle aspiration cytology: a meta-analysis
Erica Eugster (2010)
10.1210/jc.2005-1705
The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
Francesco Boi (2006)
Comparison of (123)I and (131)I for whole-body imaging in thyroid cancer.
Salil D. Sarkar (2002)
10.1089/thy.2010.0353
Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma.
Kiminori Sugino (2011)
10.6004/JNCCN.2010.0095
Initial management and follow-up of differentiated thyroid cancer in children.
Steven G. Waguespack (2010)
10.1089/thy.2009.0110
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S. Cooper (2009)
10.1530/EJE-07-0088
Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer.
Nuno Cunha (2007)
10.1002/1097-0142(19910415)67:8<2186::AID-CNCR2820670830>3.0.CO;2-0
Differentiated thyroid carcinomas in children and adolescents.
Aban M Samuel (1991)
10.1016/j.otohns.2006.04.004
Thyroid Cancer in Children: Management and Outcome Experience of a Referral Center
Aron Popovtzer (2006)
10.1038/sj.bjc.6601319
Second primary malignancies in thyroid cancer patients
Corrado Rubino (2003)
10.1097/00006254-199310000-00003
Pregnancy After High Therapeutic Doses of Iodine-131 in Differentiated Thyroid Cancer: Potential Risks and Recommendations
Dario Casara (1993)
10.1089/thy.2012.0051
Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
Kiminori Sugino (2012)
10.1016/s0084-3741(08)79067-x
Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
Matthias Schott (2008)
10.1210/jc.2005-0492
A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
Richard T. Kloos (2005)
10.1016/j.ecl.2007.04.002
Thyroid cancer in children.
Catherine A. Dinauer (2007)
10.1210/jcem.84.11.6094
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
B Haugen (1999)
10.1089/thy.2012.0468
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Pallavi Iyer (2014)
10.1677/erc.1.00880
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Barbara Jarzab (2005)
10.1089/thy.2011.2111.com
Historical note: TSH suppression for thyroid cancer.
James Ross Hurley (2011)
10.1111/j.1365-2265.1985.tb00186.x
The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer.
A. W. G. Goolden (1985)
10.1677/erc.1.00882
Pathogenesis, diagnosis and management of thyroid nodules in children.
Marek Niedziela (2006)
10.1530/eje.1.02158
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
Furio Pacini (2006)
10.1210/jc.2008-0962
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
Won Gu Kim (2008)
10.7326/0003-4819-139-5_Part_1-200309020-00010
Disappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens
Luca Chiovato (2003)
10.1007/s00423-013-1140-z
Minimally invasive follicular thyroid cancer (MIFTC)—a consensus report of the European Society of Endocrine Surgeons (ESES)
Gianlorenzo Dionigi (2013)
10.1210/jc.2003-031573
Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.
Richard J Robbins (2004)
10.1002/jso.20700
Pathology and genetics of thyroid carcinoma.
Ronald A DeLellis (2006)
10.1089/thy.2008.0429
The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.
Steven G. Waguespack (2009)
10.1530/ERC-13-0066
Differentiated thyroid carcinoma: defining new paradigms for postoperative management.
Cosimo Durante (2013)
10.1007/s00268-004-7605-z
Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma
Geoffrey Thompson (2004)
10.2967/jnumed.106.035535
Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer
Daria Handkiewicz-Junak (2007)
10.1667/RR3605.1
Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its Modifiers
Cécile M. Ronckers (2006)
10.1210/jc.2002-021365
Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.
Eric Baudin (2003)
10.1111/j.1365-2265.2009.03693.x
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
Ji Hyoung Seo (2010)
10.1089/thy.2011.0322
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.
Ji Min Han (2012)
10.1210/jc.2007-0444
Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer.
Sophie Leboulleux (2007)
10.1089/thy.1999.9.421
An overview of the management of papillary and follicular thyroid carcinoma.
Ernest L. Mazzaferri (1999)
10.1002/pbc.10421
A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster.
Marek Niedziela (2004)
10.1148/radiol.2352031942
Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US.
Andrej Lyshchik (2005)
10.4158/EP.6.5.401
Management of thyroid cancer: radioiodine ablation, "stunning," and treatment of thyroglobulin-positive, (131)I scan-negative patients.
James Ross Hurley (2000)
10.1089/thy.2012.0606
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
Frederik Anton Verburg (2013)
10.1007/s00259-009-1368-6
Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer
Chao Ma (2009)
10.1002/hed.21079
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma.
Gary L Clayman (2009)
10.1046/j.1365-2265.2002.t01-1-01545.x
Testicular dose and fertility in men following I(131) therapy for thyroid cancer.
Stephen Hyer (2002)
who receive radioactive iodine therapy
AM Sawka (2011)
10.1210/er.2012-1038
Evolving approaches to patients with advanced differentiated thyroid cancer.
B Haugen (2013)
10.6004/JNCCN.2010.0094
Complications of radioactive iodine treatment of thyroid carcinoma.
Stephanie L. Lee (2010)
10.1515/JPEM.2003.16.7.1033
Treatment of Recurrent Papillary Thyroid Carcinoma in Children and Adolescents
Patricia A.G. Powers (2003)
10.1016/j.medin.2017.10.003
Systematic review and meta-analysis.
Miguel Delgado-Rodríguez (2018)
Rising incidence of second cancers in patients with low - risk ( T 1 N 0 )
NG Iyer
10.1210/jc.2002-021925
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma.
Furio Pacini (2003)
10.1210/jcem.83.4.4683
Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Carole A. Spencer (1998)
10.1089/THY.2012.0468
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
IyerPallavi (2014)
10.1210/jc.2011-1740
Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
Carole A. Spencer (2011)
10.1046/j.1365-2265.2002.01574.x
Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma?
Jeroen Schaap (2002)
10.1259/0007-1285-59-702-583
Oedema of the neck after ablation of the thyroid with radioactive iodine.
A. W. G. Goolden (1986)
10.1007/s00259-008-0761-x
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
Michael Lassmann (2008)
10.1016/j.clon.2011.01.160
The Chernobyl thyroid cancer experience: pathology.
Virginia A. Livolsi (2011)
10.1111/j.1445-5994.2006.01149.x
Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy.
W. F. Eddie Lau (2006)
10.1007/BF02724312
Differentiated thyroid cancer
Ajay Kumar (2003)
10.1016/0002-9343(94)90321-2
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Ernest L. Mazzaferri (1994)
Recurrence and morbidity in differentiated thyroid carcinoma in children.
Michael La Quaglia (1988)
10.1038/ncpendmet0020
Thyroid-hormone therapy and thyroid cancer: a reassessment
Bernadette Biondi (2005)
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Kunihiro Nakada (2005)
10.1089/thy.2012.0183
Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.
Jonathan Hugo (2012)
10.1089/thy.2014.0460
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
Gary L. Francis (2015)
10.1089/105072501753271707
Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer.
Gabriella Pellegriti (2001)
The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.
Richard S. Benua (1962)
10.1089/thy.2009.0386
Thyroid cancer in childhood: a retrospective review of childhood course.
Clodagh S M O'Gorman (2010)
10.1089/thy.2009.0266
Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.
Libo Chen (2010)
10.4158/EP.12.1.63
American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.
H. Gharib (2006)
10.1111/j.1365-2265.2004.02060.x
Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
Carmen F A Eustatia-Rutten (2004)
10.1089/105072503322021142
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer.
Alessandro Antonelli (2003)
10.1200/JCO.2008.21.1920
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
Anna T. Meadows (2009)
10.1016/j.amjsurg.2010.03.009
Global variation in the pattern of differentiated thyroid cancer.
Stacey L Woodruff (2010)
Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
Massimo Eugenio Dottorini (1995)
10.1111/j.1365-2265.2008.03222.x
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.
Anna M Sawka (2008)
10.1111/j.1365-2362.2009.02162.x
Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination.
Sabine Guth (2009)
10.1210/jc.2012-4172
Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.
Andrew N Hoofnagle (2013)
10.1002/(SICI)1097-0347(199809)20:6<549::AID-HED10>3.0.CO;2-R
Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up.
R. Vassilopoulou-sellin (1998)
10.1586/17446651.4.1.25
Diagnosis and management of thyroid carcinoma: a focus on serum thyroglobulin
Stefan K. G. Grebe (2009)
Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid?
Jamshid Farahati (1999)
10.1210/jcem.86.10.7950
Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches.
Andrea Corrias (2001)
10.1590/S0004-27302007000500012
Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present.
Yuri E. Demidchik (2007)
10.1002/cncr.26045
Oncofertility and preservation of reproductive capacity in children and young adults.
W. Hamish B. Wallace (2011)
10.1007/s002590000271
Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children
Barbara Jarzab (2000)
10.1089/thy.2006.0234
Lung transplantation for pulmonary metastases and radiation-induced pulmonary fibrosis after radioactive iodine ablation of extensive lung metastases from papillary thyroid carcinoma.
James S Lee (2007)
Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected.
James C. Sisson (1983)
10.1002/cncr.11031
Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
Andrea Frasoldati (2003)
10.1016/S0140-6736(14)60421-9
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose (2014)
10.1089/thy.1994.4.199
Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma.
Ajay Kumar (1994)
10.1002/hed.21492
Positron emission tomography and positron emission tomography-CT evaluation for recurrent papillary thyroid carcinoma: meta-analysis and literature review.
Mia E Miller (2011)
10.1089/thy.2008.0392
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Anna M Sawka (2009)
10.1097/RLU.0b013e3181b7dbb1
A Comparison Between Diagnostic I-123 and Posttherapy I-131 Scans in the Detection of Remnant and Locoregional Thyroid Disease
Damita L Thomas (2009)
10.1210/jc.2013-1059
Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
Christoph Reiners (2013)
10.1097/01.rlu.0000127090.66051.eb
Correlation Between Cervical Uptake and Results of Postsurgical Radioiodine Ablation in Patients With Thyroid Carcinoma
Pedro Weslley Rosario (2004)
10.1016/j.surg.2007.09.015
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
E Mirallié (2007)
10.1111/j.1365-2265.2007.03081.x
A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors.
Anna M Sawka (2008)
10.1007/s00268-001-0198-x
Metastatic Differentiated Thyroid Carcinoma: ClinicopathologicalProfile and Outcome in an Iodine Deficient Area
Anjali Mishra (2001)
Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
Aban M Samuel (1998)
10.1007/s00259-009-1303-x
Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
Frederik A. Verburg (2009)
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.
Ferdinand Peter Moog (2000)
10.1002/1097-0142(20010201)91:3<505::AID-CNCR1029>3.0.CO;2-6
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature.
Lester D. R. Thompson (2001)
Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.
Furio Pacini (1994)
10.2298/aci0303107k
Follicular thyroid carcinoma
Ksenija Krgović (2003)
10.1097/00000478-198604000-00003
Risk Factors in Follicular Thyroid Carcinomas: A Retrospective Follow-up Study Covering a 14-Year Period with Emphasis on Morphological Findings
Winfried Lang (1986)
10.1016/S0001-2998(82)80009-3
Drug-induced changes in the biologic distribution of radiopharmaceuticals.
W B Hladik (1982)
10.1634/theoncologist.2010-0405
Follicular adenoma and carcinoma of the thyroid gland.
C. R. Mchenry (2011)
10.1001/archpedi.162.6.526
Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis.
Andrea Corrias (2008)
10.1530/eje.1.01940
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.
Rainer Görges (2005)
Papillary Thyroid Carcinoma: A 10 Year Follow-Up Report of the Impact of Therapy in 576 Patients
Heno . Nevotlo (1981)
10.1089/THY.2014.0460
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
L FrancisGary (2015)
10.1007/s00405-012-2205-2
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
Giorgio Treglia (2012)
10.1097/00006231-200402000-00006
Clinical implications of the differences between diagnostic 123I and post-therapy 131I scans
Jason B Cohen (2004)
10.1210/JC.2012-1123
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?
Cosimo Durante (2012)
10.1089/thy.2011.0170
Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
Gary L Clayman (2011)
10.1007/s004230050124
Differentiated thyroid cancer in children and adolescents
Jamshid Farahati (1998)
10.1016/j.clinimag.2011.01.001
Suspiciously malignant findings on ultrasound after fine needle aspiration biopsy in a thyroid nodule with initially benign ultrasound and cytologic result: to repeat or to follow-up.
Yu-Mee Sohn (2011)
10.1089/thy.2004.14.959
Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes.
Henry J. Baskin (2004)
10.1515/JPEM.2006.19.12.1377
Evidence-based Review of Treatment and Follow up of Pediatric Patients with Differentiated Thyroid Carcinoma
Marianna Rachmiel (2006)
10.1007/s00259-010-1669-9
Favourable course of disease after incomplete remission on 131I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up
Johannes Biko (2010)
10.1089/thy.2010.0403
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
James C. Sisson (2011)
10.1007/s00259-011-1788-y
Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level
Heribert Haenscheid (2011)
10.1002/pbc.10410
Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
Sin-Ming Chow (2004)
Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers.
Jan Němec (1979)
Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
Salil D. Sarkar (1976)
10.1053/jpsu.2002.36214
Pediatric surgical images: PET evaluation of papillary thyroid carcinoma recurrence.
Simon Armstrong (2002)
10.1007/s00259-003-1174-5
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
Elif Hindié (2003)
10.1210/jc.2002-021702
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Ernest L. Mazzaferri (2003)
10.1259/0007-1285-50-599-799
Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine.
Caroline J. Edmonds (1977)
10.1677/ERC-08-0335
New therapeutic advances in the management of progressive thyroid cancer.
Jennifer A Woyach (2009)
10.1210/jc.2011-3017
Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.
Ana Maria Chindriş (2012)
10.1089/thy.2009.0466
Salivary gland malignancy and radioiodine therapy for thyroid cancer.
Joanna Klubo-Gwiezdzinska (2010)
10.2967/jnumed.108.061382
Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
Ravinder Kaur Grewal (2009)
10.1046/j.1365-2265.2002.01592.x
Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation.
J-K Chung (2002)
10.1288/00005537-198012000-00010
Thyroid carcinoma.
Robert Michael Tuttle (2010)
Pathology and genetics of tumours of endocrine organs
Ronald A DeLellis (2004)
10.1097/00000658-199804000-00014
Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group.
Kurt D. Newman (1998)
10.1016/S0959-8049(99)00281-6
Thyroid cancer in children: the Royal Marsden Hospital experience.
Daryl Landau (2000)
The use of dosimetry in the treatment of differentiated thyroid cancer.
Michael Lassmann (2011)
10.1097/CCO.0b013e32835a9ab1
Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer
Luca Giovanella (2013)
10.1245/s10434-010-1083-3
Utilization of Total Thyroidectomy for Differentiated Thyroid Cancer in Children
Mehul V. Raval (2010)
10.1007/978-3-319-60570-8
The Bethesda System for Reporting Thyroid Cytopathology
Dharmendra Kumar (2018)
10.1089/thy.1995.5.165
Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma.
B Schaadt (1995)
10.1038/ncpendmet0757
Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
Carole A. Spencer (2008)
10.1001/jama.283.17.2272
Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma.
Perry Grigsby (2000)
10.1002/1097-0142(19930215)71:4<1348::AID-CNCR2820710429>3.0.CO;2-3
Pulmonary metastases in children and young adults with differentiated thyroid cancer.
R. Vassilopoulou-sellin (1993)
10.1210/jcem.87.7.8702
Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
Richard J Robbins (2002)
American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Kaliszewski (2017)
10.1089/10507250152741028
Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
Wenli Wang (2001)
False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs.
Concetto Regalbuto (2002)
10.1089/thy.2009.0446
Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review.
Melissa Pawelczak (2010)
10.1089/thy.2006.16.109
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S. Cooper (2006)
10.1007/s00259-011-1841-x
Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl
Helge Hebestreit (2011)
10.1097/01.sla.0000205977.74806.0b
Comprehensive Clinical Assessment of 740 Cases of Surgically Treated Thyroid Cancer in Children of Belarus
Yuri E. Demidchik (2006)
10.1016/j.jss.2009.03.098
Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.
Anthony Richard Hogan (2009)
10.1002/cncy.21199
Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration.
Sara E Monaco (2012)
10.1210/jc.2005-1550
Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.
Sonia Iorcansky (2005)
10.1210/jc.2003-031139
Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
Dina I. Serhal (2004)
10.1016/j.suronc.2007.05.004
Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Jen-Der Lin (2007)
10.1210/jc.2002-020210
Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.
Richard T. Kloos (2002)
10.1002/1097-0142(197602)37:2+<1111::AID-CNCR2820370821>3.0.CO;2-E
The effects of gonadal irradiation in clinical radiation therapy: a review.
Clarence C. Lushbaugh (1976)
10.1089/thy.2013.0496
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
Carole A. Spencer (2013)
10.1210/jc.2007-1154
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Aaron P. Brown (2008)
10.1053/jpsu.2000.6935
Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
Michael La Quaglia (2000)
10.1016/b978-012374212-4.50152-8
Diagnosis of Thyroid Cancer in Children
Andrej Lyshchik (2008)
10.1056/NEJM199709253371304
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.
Paul Ladenson (1997)
10.1159/000320028
Pediatric Graves’ Disease: Controversies in Management
Scott A. Rivkees (2010)
10.1089/thy.1998.8.737
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
David S. Cooper (1998)
10.1002/(SICI)1097-0142(19971201)80:11<2156::AID-CNCR16>3.0.CO;2-Y
Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology.
Jamshid Farahati (1997)
STRUCTURAL CHANGES IN THE THYROID GLANDS OF HEALTHY YOUNG MEN.
James E. Oertel (1965)
10.1016/j.surg.2011.09.023
Predictive factors of malignancy in pediatric thyroid nodules.
Rashmi Roy (2011)
10.1210/jcem.87.4.8274
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment.
Furio Pacini (2002)
10.1210/jc.2013-2259
Approach to the patient: role of dosimetric RAI Rx in children with DTC.
Frederik Anton Verburg (2013)
10.1002/cncr.21055
The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
Andreas Machens (2005)
10.1007/s00259-002-0785-6
Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I
Thomas E. Hilditch (2002)
10.1210/jc.2010-0898
Approach to the pediatric patient with Graves' disease: when is definitive therapy warranted?
Andrew J Bauer (2011)
10.1667/RRAV05.1
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995.
Elaine Ron (2012)
10.4158/EP.4.5.282
Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin.
M L Adler (1998)
10.1067/msy.2000.109728
Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis.
Jeromy S. Brink (2000)
10.1046/j.1365-2265.2003.01735.x
Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma.
Maurice J H M Pluijmen (2003)
10.1515/JPEM.2003.16.5.693
Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents
Patricia A.G. Powers (2003)
10.1210/jc.2007-1404
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.
Maria Grazia Castagna (2008)
10.1001/jama.1946.02870490016004
Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid.
S. M. Seidlin (1946)
10.1056/NEJMoa1406470
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin G. Schlumberger (2015)
10.1530/EJE-13-0386
Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation.
Camila Nascimento (2013)
10.1097/01.RLU.0000048678.96894.9A
Comparison of I-123 and I-131 for Whole-Body Imaging After Stimulation by Recombinant Human Thyrotropin: A Preliminary Report
Gregory D. S. Anderson (2003)
10.1097/MNM.0b013e32832dcfa7
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
Meng-Jie Dong (2009)
10.1210/jc.2013-1796
A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.
Anjuli Gupta (2013)
10.1210/er.2011-0011
The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.
Scott A. Rivkees (2011)
10.1089/thy.2010.0355
Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
Akira Miyauchi (2011)
10.1038/sj.ejcn.1600935
Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values
N Knudsen (2000)
10.1136/pmj.78.916.92
Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer
Louiza Vini (2002)
Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
José Manuel Carril (1997)
10.1016/S0001-2998(78)80009-9
The treatment of thyroid carcinoma with radioactive iodine.
William H. Beierwaltes (1978)
Fertility and birth histories of patients treated with I-131 for thyroid cancer before 1969 at 20 years or less
SD Sarkar (1976)
10.1007/s10637-007-9091-2
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer
Athanassios Argiris (2007)
10.1210/jc.2005-1534
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
Richard J Robbins (2006)
10.1007/s00259-006-0341-x
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement
Muammer Urhan (2006)
10.1111/j.1365-2265.2010.03898.x
Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
Joanna Kłubo-Gwieździńska (2011)
10.1089/105072502760258668
Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review.
Wellington Hung (2002)
10.1210/jc.2009-0593
Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.
Markus Luster (2009)
10.1007/s00268-009-0364-0
Long-Term Outcome in 215 Children and Adolescents with Papillary Thyroid Cancer Treated During 1940 Through 2008
Ian D. Hay (2009)
10.1007/s002590050535
Testicular function after radioiodine therapy for thyroid carcinoma
Maria Wichers (2000)
STRUCTURAL CHANGES IN THE THYROID GLANDS OF HEALTHY YOUNG MEN.
Oertel Je (1965)
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
Robert Michael Tuttle (2006)
10.1016/j.surg.2008.07.021
Is nodule size an independent predictor of thyroid malignancy?
C. R. Mchenry (2008)
10.1089/thy.2015.0020
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
B Haugen (2016)
10.1046/j.1365-2265.1998.00584.x
Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults.
C A Welch Dinauer (1998)
10.1002/hed.21373
Diminishing diagnosis of follicular thyroid carcinoma.
Kristen J. Otto (2010)
10.1210/jc.2005-1185
Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy.
Massimo Torlontano (2006)
10.1002/cncr.10725
Childhood and adolescent thyroid carcinoma.
Perry Grigsby (2002)
10.1002/dc.20197
Thyroid fine-needle aspiration biopsy in children and adolescents: experience with 218 aspirates.
Mojghan Amrikachi (2005)
10.1046/j.1365-2265.2002.01611.x
Gonadal damage from 131I therapy for thyroid cancer.
Ernest L. Mazzaferri (2002)
10.1677/erc.0.0090227
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
Ernest L. Mazzaferri (2002)
10.1007/s00268-008-9742-2
Risk Factors for Lateral Cervical Lymph Node Involvement in Follicular Thyroid Carcinoma
Haitham Alfalah (2008)
10.1210/jcem-71-2-414
Natural history, treatment, and course of papillary thyroid carcinoma.
Leslie J. Degroot (1990)
10.1097/00003072-198303000-00006
Low Iodine Diet in I-131 Ablation of Thyroid Remnants
Harry R. Maxon (1983)
10.1159/000351029
Indeterminate Pediatric Thyroid Fine Needle Aspirations: A Study of 68 Cases
Matthew A. Smith (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar